Jahnz H, Hamann MV, Kim H, Sun Y, Salazar-Quiroz N, Zhu L, Leddy SM, Swaiba UE, Schneider C, Foth D, Beschorner N, Kumar P, Lange UC (2026). Development of a Recombinant Adeno-Associated Virus Vector for Human T Lymphocyte- and Natural Killer Cell-Targeted Gene Therapy.
Hum Gene Ther. 2026 Sep 16;
PubMed
Ma T, George AF, Li Z, Thomas R, Yin K, Shin MG, Montano M, Matsui Y, Ashokkumar M, Young K, Prigann J, Frouard J, Leddy S, Adiba M, Herrde C, Lange UC, Feschotte C, Nixon DF, Browne EP, Archin NM, Li JZ, Smith D, Deeks S, Søgaard OS, Tolstrup M, Lee S, Pillai SK, Abdel-Mohsen M, Pollard KS, Siliciano R, Ott M, Greene WC, Roan NR (2026). Multiomic analysis of ART-interruption cohorts identifies cell-extrinsic and -intrinsic mechanisms driving lymphocyte-mediated control of HIV rebound.
Immunity. 2026 Mar 20;
PubMed
Hamann, M. V., Brauckmann, L., Schwarz, C., Spohn, M., Stoeck, R., Leddy, S. M., Frouard, J., Adiba, M., Winzer, R., Virdi, S., Grundhoff, A., Feschotte, C., Muecksch, F., Roan, N. R., Tolosa, E. & Lange, U. C. (2026). Selective persistence of HIV-1-infected T cell clones can occur through immune reprogramming driven by defective, transcriptionally active proviruses
bioRxiv.
URI
